Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

1 week AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

AbbVie (ABBV)

  X     

17 hours AbbVie’s Stock Is Unfairly Cheap Seeking Alpha

   X     

1 day Opinion on my current portfolio Reddit

   X     

2 days AbbVie (ABBV) Stock Moves -0.32%: What You Should Know Zacks

   X     

3 days Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

3 days AbbVie cuts 2024 profit forecast on acquisition expenses Investing.com

   X     

1 week The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

1 week AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks

   X     

1 week Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet Zacks

   X     

2 weeks AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

3 weeks Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

   X     

3 weeks Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks

   X     

3 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

   X     

3 weeks AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

   X     

3 weeks AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

   X     

4 weeks ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

   X     

4 weeks ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

   X     

4 weeks Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha

   X     

1 month AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks

   X     

1 month The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

1 month Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

1 month AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch

   X     

1 month AbbVie reports positive results in Parkinson’s trial Investing.com

   X     

1 month Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube

   X     

1 month AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

   X     

1 month Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

   X     

1 month Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance

   X     

1 month Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks

   X     

2 months Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead Seeking Alpha

   X     

2 months AbbVie Stock Rises After Leerink Partners Upgrades Its Rating Zacks

   X     

2 months AbbVie: Upgrading To ‘Strong Buy’ After Pullback Seeking Alpha

   X     

2 months Trade Tracker: Jim Lebenthal buys more Abbvie YouTube

   X     

2 months AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

   X     

2 months AbbVie, Nvidia Lead Friday’s Market Cap Stock Movers Investing.com

   X     

2 months Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks

   X     

2 months Where Will AbbVie Be in 5 Years? Yahoo Finance

   X     

2 months AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in Europe Zacks

   X     

2 months Dividend King AbbVie Just Paid Investors: Here’s How Much They Got 24/7 Wall St.

   X     

2 months Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline Setback Zacks

   X     

2 months AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? Zacks

   X     

2 months Final Trades: Bitcoin, Abbvie and Baker Hughes YouTube

   X     

2 months Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects Seeking Alpha

   X     

2 months AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio Yahoo Finance

   X     

2 months Final Trades: Lyft, Meta, United States Oil Fund & Abbvie YouTube

   X     

2 months AbbVie And Pfizer: Q3 Dividend Checkup Post-Earnings Seeking Alpha

   X     

2 months Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade) Seeking Alpha

   X     

2 months AbbVie Stock: Keep Calm And Buy The Dip Seeking Alpha

   X     

2 months Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

   X     

2 months AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials Yahoo Finance

   X     

2 months RHHBY or ABBV: Which Is the Better Value Stock Right Now? Zacks

   X     

2 months Analyst Report: AbbVie Inc Yahoo Finance

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News